Ye‐Ran Wang

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Neuroinflammation in Parkinson’s disease and its potential as therapeutic target

Parkinson disease

The glymphatic pathway in neurological disorders

Ageing as a risk factor for neurodegenerative disease

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

Plasma-Based Strategies for Therapeutic Modulation of Brain Aging

Gut microbiota: Implications in Parkinson's disease

Caspases and their role in inflammation and ischemic neuronal death. Focus on caspase-12

Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions

Activation of apoptosis signalling pathways by reactive oxygen species

Gastric cancer

Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system

The neuropathological diagnosis of Alzheimer’s disease

Gut Microbiota is Altered in Patients with Alzheimer’s Disease

Inflammation as a central mechanism in Alzheimer's disease

Can Microbiota Research Change Our Understanding of Neurodegenerative diseases?

Reduced Cardiovascular Functions in Patients with Alzheimer’s Disease

Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels—Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance

Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease

The association between infectious burden and Parkinson's disease: A case-control study

Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance

Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery

Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies